Literature DB >> 15500872

Drug-eluting stents: some bare facts.

Mark J Eisenberg1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15500872     DOI： 10.1016/S0140-6736(04)17287-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Cost effectiveness of drug-eluting stents in Belgian practice: healthcare payer perspective.

Authors:  Mattias Neyt; Chris De Laet; Annemieke De Ridder; Hans Van Brabandt
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 2.  Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature.

Authors:  J Carlsson; B von Wagenheim; R Linder; T M Anwari; J Qvist; I Petersson; T Magounakis; B Lagerqvist
Journal:  Clin Res Cardiol       Date:  2006-12-22       Impact factor: 5.460

3.  Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells.

Authors:  Hai-Tao Liu; Fei Li; Wen-Yong Wang; Xiao-Jing Li; Yi-Meng Liu; Rui-An Wang; Wen-Yi Guo; Hai-Chang Wang
Journal:  Tex Heart Inst J       Date:  2010

4.  Intractable intraoperative bleeding requiring platelet transfusion during emergent cholecystectomy in a patient with dual antiplatelet therapy after drug-eluting coronary stent implantation (with video).

Authors:  Takahisa Fujikawa; Tomohiro Noda; Seiichiro Tada; Akira Tanaka
Journal:  BMJ Case Rep       Date:  2013-03-26

5.  External adjustment sensitivity analysis for unmeasured confounding: an application to coronary stent outcomes, Pennsylvania 2004-2008.

Authors:  Marco D Huesch
Journal:  Health Serv Res       Date:  2012-12-03       Impact factor: 3.402

6.  Successful resection of complicated bleeding arteriovenous malformation of the jejunum in patients starting dual-antiplatelet therapy just after implanting a drug-eluting coronary stent.

Authors:  Takahisa Fujikawa; Hisatsugu Maekawa; Kei Shiraishi; Akira Tanaka
Journal:  BMJ Case Rep       Date:  2012-09-24

7.  Sirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.

Authors:  Shengsi Zhu; Hema Viswambharan; Thusitha Gajanayake; Xiu-Fen Ming; Zhihong Yang
Journal:  BMC Cardiovasc Disord       Date:  2005-07-15       Impact factor: 2.298
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.